Richard S. Shames, Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 2,778 shares at $7.71 ($22K) on 2019-02-06, disclosed to the SEC on 2019-02-08.
Open-market sale of $22k PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.71 | 2,580 | $20K | 92.5% |
| 2 | $8.15 | 198 | $2K | 7.5% |
| Total | $7.74 avg | 2,778 | $22K | 100% |
| Filing → |
| PTGX | SELL | 2017-10-10 | $38K | — | Filing → |
| PTGX | SELL | 2017-09-12 | $106K | — | Filing → |
| PTGX | SELL | 2017-08-30 | $26K | — | Filing → |